NCT02641509

Brief Summary

Interval colon cancers are an important clinical issue. A recent paper from Pohl et al focused on non-pedunculated polyps of 5-20 mm, evaluating non complete polypectomy revealing that 10% of these polyps were not completely resected. This fact was attributed to size and histology. In this study the investigators want to evaluate the radical resection of non-pedunculated polyps of 5-20 mm by performing biopsies on the margins immediately after polypectomy, to establish if the use of Narrow Band Imaging (NBI) could be useful in the definition of the margins of the lesion before polypectomy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2015

Completed
29 days until next milestone

First Posted

Study publicly available on registry

December 29, 2015

Completed
3 days until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

May 21, 2020

Status Verified

May 1, 2020

Enrollment Period

3.8 years

First QC Date

November 30, 2015

Last Update Submit

May 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • NBI efficacy in predicting radicality of polypectomy by taking random biopsies of margins after resection of the lesion

    12 months

Study Arms (2)

NBI to perform the polipectomy

EXPERIMENTAL

this arm will undergo polypectomy with the use of NBI to define the margins of the lesion

Device: NBI during polypectomy

no NBI to perform the polypectomy

EXPERIMENTAL

this arm will undergo polipectomy without the use of NBI to define the margins of the lesion

Device: no NBI during polypectomy

Interventions

NBI to perform the polipectomy

NBI to perform the polipectomy

no NBI to perform the polypectomy

no NBI to perform the polypectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Every polyp ≥ 5 mm and ≤ 20 mm

You may not qualify if:

  • Inflammatory bowel Disease and/or International Normalized Ratio \> 1.5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Valduce Hospital

Como, 22100, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 30, 2015

First Posted

December 29, 2015

Study Start

January 1, 2016

Primary Completion

October 1, 2019

Study Completion

October 1, 2019

Last Updated

May 21, 2020

Record last verified: 2020-05

Locations